Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

C4 Therapeutics Inc.

www.C4Therapeutics.com

Latest From C4 Therapeutics Inc.

Gilead Dives Into Protein Degradation With Nurix Pact

Gilead is elbowing its way into the protein degradation field, seeking to build out a pipeline of oncology drugs in a $45m deal with Nurix. The pool is becoming crowded though, as many other big firms have latched onto this burgeoning field of R&D.

Companies Deals

How Can Korea Grab Window Of Opportunity In AI Drug Development?

Participants at a recent policy forum in Seoul stressed the need to secure appropriate technology and expertise, unify government support and draw up a joint cooperation plan between industry and government as key factors in advancing AI-guided new drug development in South Korea.

South Korea Artificial Intelligence

Novartis' Drug Discovery Head Jay Bradner On What NIBR Is Investing In

NIBR's Bradner talked to Scrip about how AveXis turbo-charged Novartis' gene therapy development, investing in inflammasome research, and partnering nimbly like a venture capitalist.

Leadership Research and Development Strategies

Bayer Pays Arvinas $50m To Form Protein Degrader R&D Pact

The partnership gives the German major another potential source of drugs to treat cardiovascular, oncological and gynecological diseases.

Deals Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gastrointestinal
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • C4 Therapeutics Inc.
  • Senior Management
  • Andrew Phillips, PhD, Pres. & CEO
    Ron Kaiser, CFO
    Michael Kim, PhD, VP, Bus. Dev.
    Stewart Fisher, PhD, CSO
    Adam Crystal, MD, PhD, CMO
  • Contact Info
  • C4 Therapeutics Inc.
    Phone: (617) 231-0700
    490 Arsenal Way, Ste. 200
    Watertown, MA 02472
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register